Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Botanix Pharmaceuticals Limited ( (AU:BOT) ) has provided an announcement.
Botanix Pharmaceuticals Limited has announced its Annual General Meeting (AGM) scheduled for November 20, 2025, in Perth, Western Australia. The meeting will address key business matters, including the consideration of financial reports and a non-binding resolution on the remuneration report for the year ended June 30, 2025. This AGM is crucial for shareholders to engage with the company’s financial and strategic direction, impacting its governance and stakeholder relations.
The most recent analyst rating on (AU:BOT) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Botanix Pharmaceuticals Limited stock, see the AU:BOT Stock Forecast page.
More about Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of dermatology and antimicrobial products. The company leverages its proprietary drug delivery technology to enhance the effectiveness of its products, targeting significant unmet medical needs in these areas.
Average Trading Volume: 8,929,196
Technical Sentiment Signal: Sell
Current Market Cap: A$315.3M
For detailed information about BOT stock, go to TipRanks’ Stock Analysis page.